Trial Profile
A Multicenter, Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Efficacy of Oral AB1010 in Adult Patients With Severe Persistent Corticosteroid Dependent Asthma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2018
Price :
$35
*
At a glance
- Drugs Masitinib (Primary)
- Indications Asthma
- Focus Proof of concept; Therapeutic Use
- Sponsors AB Science
- 01 Aug 2009 Results published in Allergy.
- 18 Feb 2009 New trial record